✦ NHS ENGLAND PROCUREMENT WINNER
Digital weight management
across the entire pathway
Evidence-based remote monitoring and behavioural treatment for children, young people and adults. Used by NHS specialist services and private providers across the UK.
WHO ARE YOUR PATIENTS?
Children & Young People
CEW specialist services, community paediatrics, Tier 2 lifestyle programmes, schoole health
Adults
NHS Tier 3, bariatric pre-op, GP-referred programmes, GLP-1 behavioural support
7,000+
PAEDIATRIC PATIENTS
6,000+
ADULT USERS
2x
BETTER OUTCOMES
7
COUNTRIES
60+
CENTRES
⚡ THE CHALLENGE
Short-term programmes aren't solving a long-term problem
Obesity is a chronic condition — but most services deliver short-term, clinic-based programmes of around 12 weeks. These are resource-intensive, difficult to sustain, and drive repeat demand. In England, 66% of adults and 26% of children aged 2–15 are overweight or living with obesity.
Evira takes a different approach: continuous digital support alongside clinical care, enabling long-term follow-up without proportional increases in staffing. Not episodic 12-week care — sustained behavioural change.
£6.5bn
NHS obesity costs per year
£58bn
Annual full cost of obesity in the UK
14m
People living with obesity in the UK
NHS Digital 2024, Health Survey for England, Jan 2026
✦ DIGIPHYSICAL CARE
We combine digital and physical care
Evira bridges the gap between clinic visits with daily remote monitoring, family messaging, and proactive intervention — enabling high-quality care even when distances are great.
⚖️
Daily remote monitoring
Connected scale at home — no numbers displayed. Daily measurements flow to the clinical dashboard automatically.
💬
In-app messaing
Families message their care team anytime. AI-powered translation supports multilingual populations.
📊
MDT clinical dashboard
Full treatment history accessible for multidisciplinary team. Patient overview with search, filter and sort. 2–4 minutes per patient per week.
📈
AI growth estimation
Individualised height growth predictions per patient alongside weight trends. Yields real-time accurate BMI SDS values over time for children and young people.
🌍
10+ languages, traffic-light design
Simple visual indicators for varying health literacy. AI translation in messaging. Accessible to diverse populations.
👨👩👧
Whole-family approach
Multiple household members can use the same device with separate secure accounts — supporting family-wide collaboration.
🔒 PROCUREMENT-READY
Information governance & compliance
DTAC, DSPT, Cyber Essentials, DCB0129, CE marked, ICO registered. We provide complete evidence packs to accelerate your procurement.
🔒
DTAC compliant
Digital Technology Assessment
⚕️
DCB0129 & DCB0160
Clinical risk management
🛡️
DSP Toolkit
Data Security & Protection
🏷️
CE Marked
Medical device, class I
✅
Cyber Essentials
Certified for CE
📋
ICO Registered
UK-GDPR compliant
We can provide a complete DTAC evidence pack, help fill out DPIA templates, and data processing agreements. View full compliance documentation →
Trusted by the evidence
Clinically validated in published, peer-reviewed research with Karolinska Institutet
-0.30
BMI SDS reduction / year
Double the effect of traditional treatment with Evira.
3 yrs
Sustained outcomes
Treatment effects maintained after three years. KI follow-up, 2025.
78%
Family satisfaction
vs 11% in traditional care. Especially effective with adolescents.
🌿 SUSTAINABILITY
Supporting NHS net zero ambitions
Evira reduces environmental impact by shifting care from clinic-based to digital-first delivery.
🚗
Reduced patient travel
Home-based monitoring and digital follow-up replace many in-person visits. Fewer journeys for patients and staff.
♻️
Device reuse
The numberless scale is durable, reusable, and can be refurbished when returned. Multiple household members share one device.
📲
Reduced clinic resource use
Less reliance on printed materials. Digital communication replaces letters and paper forms.
🏠
Hybrid workforce support
Clinicians can review dashboards and respond to messages remotely, reducing staff travel where feasible.